India · Delayed Price · Currency is INR GlaxoSmithKline Pharmaceuticals Company Description
GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally.
The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of herpes zoster and post-herpetic neuralgia.
It also provides specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and Trelegy Ellipta for treating chronic obstructive pulmonary disease.
In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections; CobadexCZS to treat mineral and vitamins deficiency states in adult patients; Flutivate, a skin cream for adults, children and infants; Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis; CALPOL to treat mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment of specific bacterial skin infections; BETNOVATE for skin conditions; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin associated with redness and itch.
The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001.
GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is based in Mumbai, India.
| Country | India |
| Founded | 1924 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 3,113 |
| CEO | Bhushan Akshikar |
Contact Details
Address: GSK House Mumbai, Maharashtra 400030 India | |
| Phone | 91 22 2495 9595 |
| Website | india-pharma.gsk.com |
Stock Details
| Ticker Symbol | GLAXO |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE159A01016 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Bhushan Akshikar | MD and Executive Director |
| Juby Chandy | Whole-Time Director and Chief Financial Officer |
| Aparajita Rajput | Vice President of Technology |
| Ajay Avinash Nadkarni | Vice President of Administration and Real Estate and Company Secretary |
| Amit G. Pandey | Executive Vice President of Legal |
| Dr. Simrat Sohal | Vice President of Ethics and Compliance |
| Carson Dalton | Executive Vice President of Communications and Government Affairs |
| Harsh V. Trehan | Executive Vice President of Human Resources |
| Sukanya Choudhary | Head of Growth Emerging Market |
| Dr. Shalini Menon | Executive Vice President of Medical Affairs |